CHEMOTHERAPY IN HEAD AND NECK-CANCER .1. MANAGEMENT OF RECURRENT OR METASTATIC DISEASE

被引：0
作者：
GEBBIA, V
ZERILLO, G
GEBBIA, N
AGOSTARA, B
CALLARI, A
RAUSA, L
机构：
来源：
JOURNAL OF CHEMOTHERAPY | 1992年 / 4卷 / 04期
关键词：
HEAD NECK CANCER; SYSTEMIC CHEMOTHERAPY; METASTATIC DISEASE;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This paper is an up-dated review of the role of systemic chemotherapy in the management of recurrent and/or metastatic head and neck carcinoma.
引用
收藏
页码：244 / 259
页数：16
相关论文
共 50 条
  • [1] Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial
    Rivera, Fernando
    Garcia-Castano, Almudena
    Vega, Noelia
    Eugenia Vega-Villegas, M.
    Gutierrez-Sanz, Lourdes
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (10) : 1421 - 1428
  • [2] Head and neck cancer: metronomic chemotherapy
    De Felice, Francesca
    Musio, Daniela
    Tombolini, Vincenzo
    BMC CANCER, 2015, 15
  • [3] Metronomic chemotherapy in head and neck cancer
    De Felice, Francesca
    Benevento, Ilaria
    Musella, Angela
    Musio, Daniela
    Tombolini, Vincenzo
    CANCER LETTERS, 2017, 400 : 219 - 222
  • [4] Head and neck cancer: metronomic chemotherapy
    Francesca De Felice
    Daniela Musio
    Vincenzo Tombolini
    BMC Cancer, 15
  • [5] Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck
    D'Souza, Jacob
    Clark, Jonathan
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2011, 19 (02) : 99 - 105
  • [6] Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: Hypothesis coming from the subgroup analysis
    De Felice, Francesca
    Bossi, Paolo
    ORAL ONCOLOGY, 2023, 137
  • [7] Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer
    Caponigro, F
    Comella, P
    Budillon, A
    Bryce, J
    Avallone, A
    De Rosa, V
    Ionna, F
    Comella, G
    ANNALS OF ONCOLOGY, 2000, 11 (03) : 339 - 342
  • [8] Palliative chemotherapy with or without cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck: Indian tertiary care retrospective analysis
    Bahl, Ankur
    Bhatia, Komal
    Choudhary, Pragati
    Singhla, Suhas
    Shrivastava, Gunjan
    Bal, Jaspriya
    Anand, Anil K.
    Chaturvedi, Harit M. Ch
    Dua, Bharat
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2020, 42 (05): : 955 - 962
  • [9] Recurrent head and neck cancer: current treatment an future prospects
    Specenier, Pol M.
    Vermorken, Jan B.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (03) : 375 - 391
  • [10] Systemic therapy for recurrent and/or metastatic head and neck cancer: a population-based healthcare research study in Thuringia, Germany
    Morkramer, Lisa
    Geitner, Maren
    Boeger, Daniel
    Buentzel, Jens
    Kaftan, Holger
    Mueller, Andreas H.
    Ernst, Thomas
    Guntinas-Lichius, Orlando
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2625 - 2635
12345